SJ

Sorahunase Jayarama Reddy Venkatesh

Active Director Director DIN 11307212
DIN 11307212 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sorahunase Jayarama Reddy Venkatesh

Data last updated:

Sorahunase Jayarama Reddy Venkatesh is a Director at Curiezon Medcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11307212
Primary Designation Director
Industry Healthcare
First Appointment 25 Sep 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curiezon Medcare Private Limited U86100KA2025PTC204075
Director25 Sep 2025Active

Board colleagues of Sorahunase Jayarama Reddy Venkatesh

Directorship timeline

Open interactive timeline →
Curiezon Medcare Private Limited
Premium access

Shareholding and investment profile for Sorahunase Jayarama Reddy Venkatesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sorahunase Jayarama Reddy Venkatesh

Sorahunase Jayarama Reddy Venkatesh currently holds 1 directorship: Curiezon Medcare Private Limited (Director, since 25 Sep 2025).

Sorahunase Jayarama Reddy Venkatesh was first appointed on 25 Sep 2025 as Director at Curiezon Medcare Private Limited.

The current boards of Sorahunase Jayarama Reddy Venkatesh's companies include Bommaka Harsha Vardhana Reddy (Curiezon Medcare Private Limited), Sandeep Reddy (Curiezon Medcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available